Venous thromboembolism risk in patients with inflammatory bowel disease: defining the benefits of pharmacologic prophylaxis

Clin Gastroenterol Hepatol. 2014 Sep;12(9):1577. doi: 10.1016/j.cgh.2014.03.025. Epub 2014 Apr 1.

Authors

Keith Sultan¹, Alexander Brun¹, Alex C Spyropoulos²

Affiliations

¹ Division of Gastroenterology, North Shore-LIJ Health System, Manhasset, New York.
² Anticoagulation and Clinical Thrombosis Services, North Shore-LIJ Health System at Lenox Hill Hospital, New York, New York.

PMID: 24703865
DOI: 10.1016/j.cgh.2014.03.025

No abstract available

Publication types

Letter

MeSH terms

Chemoprevention / methods*
Chemoprevention / statistics & numerical data*
Humans
Inflammatory Bowel Diseases / complications*
Risk Assessment
Venous Thromboembolism / epidemiology*